| Financial Year |
March 31 2023 |
| Monetary Funds |
487,406,173.91 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,868,884.00 |
| Accounts Receivable |
79,383,950.13 |
| Advances to Suppliers |
1,771,013.23 |
| Other Receivables |
5,239,276.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
89,210,952.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,930,815.01 |
| Total Current Assets |
670,811,066.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
31,662,312.68 |
| Investment Properties |
-- |
| Fixed Assetes |
3,604,517.13 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,829,946.23 |
| R&D expenses |
-- |
| Goodwill |
16,781,573.37 |
| Long-Term Deferred and Prepaid Expenses |
210,695.57 |
| Deferred Income Tax Assets |
15,276,809.95 |
| Other Non-Current Assets |
2,731,262.82 |
| Sub-Total of Non-Current Assets |
137,276,777.12 |
| Total Assets |
808,087,843.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
25,627,484.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
50,506,450.07 |
| Taxes Payable |
1,767,465.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,696,805.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,710,678.22 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
139,450,153.23 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,740,462.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,555,327.92 |
| Total Liabilities |
153,005,481.15 |
| Paid-In Capital(Or Share Stock) |
72,239,774.00 |
| Capital Surplus |
403,695,522.73 |
| Surplus Reserve |
15,413,671.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
152,948,058.33 |
| Minority Stockholder's Interest |
12,545,979.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
642,536,382.93 |
| Owner's Equity（Stockholder's Equity） |
655,082,362.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
808,087,843.28 |
